← All stocks

Labcorp

LH Net selling
CIK 0000920148 #284 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$13.70M
$6.68M on a plan · $1.94M straight out of an exercise
Sold at will
$5.09M
5 of 21 sales
Net
−$13.70M
−$5.09M against sales at will

By person

24 insiders · 21 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Schechter Adam H
President & CEO
$8.44M (5) scheduled
−$8.44M
102,565
0.1265%
$32.62M
+9.5%
Parham Richelle P
Director
$1.78M (1)
−$1.78M
3,366
0.0042%
$1.07M
−60.6%
Wilkinson Peter J
SVP, Chief Accounting Officer
$1.06M (4) scheduled
−$1.06M
1,770
0.0022%
$562.97K
+2.0%
ANDERSON KERRII B
Director
$954.06K (1) scheduled
−$954.06K
6,563
0.0081%
$2.09M
−64.0%
Caveney Brian J
EVP, Pres of BLS, CMO & CSO
$429.46K (1)
−$429.46K
36,492
0.0450%
$11.61M
+29.4%
Meltzer Jonathan C
EVP, COO
$298.76K (4) scheduled
−$298.76K
3,620
0.0045%
$1.15M
+43.8%
Summy Amy B.
EVP, Chief Marketing Officer
$283.43K (1)
−$283.43K
6,956
0.0086%
$2.21M
+75.0%
Kyle Kathryn W
EVP, Chief Legal Officer
$227.41K (2) scheduled
−$227.41K
3,904
0.0048%
$1.24M
+27.9%
van der Vaart Sandra D
EVP, Corporate Affairs
$156.00K (1)
−$156.00K
6,239
0.0077%
$1.98M
+65.8%
Vaughn Bryan T
EVP and President, Diagnostics
$66.97K (1) scheduled
−$66.97K
6,746
0.0083%
$2.15M
+31.1%
EISENBERG GLENN A
Executive Vice President
37,920
0.0468%
$12.06M
+21.2%
BERBERIAN LANCE
EVP, Special Advisor, Strategy
18,652
0.0230%
$5.93M
+17.2%
NEUPERT PETER M
Director
13,784
0.0170%
$4.38M
+15.4%
Kong Garheng
Director
13,739
0.0169%
$4.37M
+15.5%
Schroeder Mark S
EVP, Pres Diagnostics & COO
12,677
0.0156%
$4.03M
+151.7%
Gilliland Dwight Gary
Director
6,656
0.0082%
$2.12M
−23.6%
Davis Jeffrey A.
Director
5,460
0.0067%
$1.74M
+50.9%
GRAHAM ANITA Z
EVP, CHRO
5,185
0.0064%
$1.65M
+1,676%
Oyegunwa Akinbolade
EVP, CIO & CTO
5,064
0.0062%
$1.61M
+89.9%
Bailey Megan D.
EVP, Pres, Central Labs & Intl
4,851
0.0060%
$1.54M
+1,013%
Wengel Kathryn E
Director
4,133
0.0051%
$1.31M
+80.3%
Kliphouse Kirsten Marie
Director
3,160
0.0039%
$1.00M
+139.6%
Rothman Paul
Director
2,571
0.0032%
$817.63K
+252.2%
Wang Julia Aijun
Chief Financial Officer, EVP
1,817
0.0022%
$577.92K
+29,027%
Insider
Date
Role
Action
Shares
Price
Amount
Summy Amy B.
4 Aug 2026
EVP, Chief Marketing Officer
Sell
924
$306.74
$283.43K
Schechter Adam H
3 Mar 2026
President & CEO
Sell
8,705
$279.96
$2.44M
van der Vaart Sandra D
27 Feb 2026
EVP, Corporate Affairs
Sell
548
$284.91
$156.00K
Caveney Brian J
24 Feb 2026
EVP, Pres of ED, CMO & CSO
Sell
1,500
$286.31
$429.46K
Parham Richelle P
31 Oct 2025
Director
Sell
7,009
$254.28
$1.78M

What was left out

Form 4 filings counted 88
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 3
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 200,494
History held since 7 Sep 2016